Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
PMAIP1, also known as Noxa, is a pro-apoptotic protein belonging to the BH3-only subfamily of the BCL-2 family. It promotes apoptosis by activating caspases and inducing mitochondrial membrane changes. Its expression is regulated by p53 and it plays a role in p53-mediated apoptotic pathways. Noxa interacts with anti-apoptotic BCL-2 family proteins like MCL-1 to neutralize their function, thereby promoting cell death.
Induction of apoptosis through neutralization of anti-apoptotic BCL-2 family members, leading to mitochondrial outer membrane permeabilization and caspase activation.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Phorbol-12-myristate-13-acetate-induced protein 1 (Noxa).